Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Boston-based Factorial has landed the strategic partnership and investments it said is needed to bring a high-performing electric vehicle battery to market by 2027. Late last year, the company ...
Karma Automotive and Massachusetts-based battery developer Factorial Energy have announced the companies are working together to bring a solid-state battery program to a production vehicle in the ...
Stellantis and Factorial Energy made a major announcement for EV batteries on April 24, 2025. The companies reported that they’ve successfully validated a powerful new solid-state battery cell, ...
Another day, another AI mega raise. Ricursive Intelligence, a frontier AI lab, announced on Monday that it has raised $300 million in a Series A round of funding at a $4 billion valuation. Notably, ...
Abstract: Computing in memory (CIM) realizes energy-efficient neural network algorithms by implementing highly parallel multiply-and-accumulate (MAC) operation. However, the MAC delay of CIM will ...
The two companies agreed to cooperate in the development of all-solid-state battery materials. In sample testing of materials from multiple suppliers, POSCO Future M demonstrated good rate capability.
Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...
Depression is one of the leading causes of global disease burden, particularly in regions with high inequality such as Latin America and the Caribbean (LAC). The Patient Health Questionnaire-9 (PHQ-9) ...
Among the myriad abilities that humans possess, which ones are uniquely human? Language has been a top candidate at least since Aristotle, who wrote that humanity was “the animal that has language.” ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results